EXCEED THE SPACE PROVIDED. Treatment of WEHI 231 or CH33 immature B lymphocytes with antisera against their expressed surface IgM (anti- IgM), which serves as B Cell Receptor (BCR), induces G1/S phase growth arrest followed by apoptosis. These cell lines have served as models for the study of tolerance via clonal deletion, and have provided important insights into mechanisms leading to death of B cell neoplasias. Work by several laboratories has demonstrated the drop in c-Myc oncogene expression resulting from BCR engagement promotes cell death. In this application, studies are focused on elucidation of how members of the c-Myc/Max/Mad network exert their affects. Work by the PI's laboratory has implicated both initiator (Inr) and E-box regulatory pathways in apoptosis mediated by anti-IgM treatment. Specifically, it has been shown: 1) the induction in p27 ripl levels is due to both transcriptional and post- transcriptional mechanisms; 2) c-Myc can repress transcription ef the p27 gene; 3) c-Myc can bind to the Inr element of the p27 gene in the presence of Max; 4) Forkhead FKHRL1 factor is induced following anti-IgM treatment; 5) transactivation of p27 promoter by FKHRL1 can be repressed by c-Myc; 6) the drop in c-Myc is followed by an increase in expression of Max negative regulatory binding partner Mad1 and a decline in E-box gene expression. 7) inhibition of ornithine decarboxylase (ODC) promotes apoptosis. These findings lead to the hypothesis that the drop in c-Myc following BCR engagement promotes cell death via two pathways: release of repression of Inr-mediated transcription and induction of repression of E-box-mediated gone expression. Experiments are proposed to:
Aim 1) Elucidate the mechanisms leading to increased p27 expression. Studies will be performed on the transcriptional activation by Forkhead proteins, the mechanism of repression by c-Myc, the involvement of Max binding partners, post-transcriptional control of p27, and identification of other Inr-containing genes de-repressed upon the drop in c- Myc. Findings on the mechanism of regulation will be extended to Jurkat T, Hs578T breast cancer, and PC12 ipheochromocytoma tumor cell lines.
Aim 2) Elucidate the role of induction of Max negative regulatory partners in repression of E-box gene transcription. Studies will be performed to characterize the changes in Max binding partner expression, and their involvement in repression of E-box regulated gene expression and the role of ODC in cell death. These findings will enhance our understanding of the mechanism of action of the c-Myc/Max/Mad network in signaling pathways that control expression of genes promoting apoptosis of tumor cells. PERFORMANCESITE( ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA036355-20
Application #
6833505
Study Section
Special Emphasis Panel (ZRG1-CAMP (01))
Program Officer
Mufson, R Allan
Project Start
1984-01-01
Project End
2007-12-31
Budget Start
2005-01-01
Budget End
2005-12-31
Support Year
20
Fiscal Year
2005
Total Cost
$303,620
Indirect Cost
Name
Boston University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Wang, Xiaobo; Belguise, Karine; O'Neill, Christine F et al. (2009) RelB NF-kappaB represses estrogen receptor alpha expression via induction of the zinc finger protein Blimp1. Mol Cell Biol 29:3832-44
Chandramohan, Vidyalakshmi; Mineva, Nora D; Burke, Brian et al. (2008) c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor. J Cell Biochem 104:2091-106
Wang, Xiaobo; Belguise, Karine; Kersual, Nathalie et al. (2007) Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat Cell Biol 9:470-8
Mineva, Nora D; Rothstein, Thomas L; Meyers, John A et al. (2007) CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis. J Biol Chem 282:17475-85
Chandramohan, Vidyalakshmi; Jeay, Sebastien; Pianetti, Stefania et al. (2004) Reciprocal control of Forkhead box O 3a and c-Myc via the phosphatidylinositol 3-kinase pathway coordinately regulates p27Kip1 levels. J Immunol 172:5522-7
Guo, Shangqin; Sonenshein, Gail E (2004) Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway. Mol Cell Biol 24:8681-90
Arsura, Marcello; Panta, Ganesh R; Bilyeu, Jennifer D et al. (2003) Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Oncogene 22:412-25
Jiang, H Y; Petrovas, Constantinos; Sonenshein, Gail E (2002) RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members. J Virol 76:5737-47
Yang, W; Shen, J; Wu, M et al. (2001) Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 20:1688-702
Jeay, S; Sonenshein, G E; Kelly, P A et al. (2001) Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinase. Endocrinology 142:147-56

Showing the most recent 10 out of 56 publications